SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number 333-125699
NOTIFICATION OF LATE FILING
(Check [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q
One): [ ] Form N-SAR
For Period Ended: December 31, 2005
---------------------------------------------------------------
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:
------------------------------------------------
READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR
TYPE.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates: ___________________
___________________________________________________________________________
PART I
REGISTRANT INFORMATION
Neuro-Hitech Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
Full name of registrant
Northern Way Resources, Inc.
- --------------------------------------------------------------------------------
Former name if applicable
One Penn Plaza, Suite 2514
- --------------------------------------------------------------------------------
Address of principal executive office (Street and number)
New York, New York 10119
- --------------------------------------------------------------------------------
City, state and zip code
PART II
RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the 15th calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day following the
prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the prescribed time period.
As previously reported, as a result of the Registrant's merger on January
24, 2006, and other material events, including the change of the Registrant's
auditors, the Registrant was unable to file the Form 10-QSB for the quarter
ended December 31, 2005 without unreasonable effort or expense.
When filed, the Form 10-QSB for the quarter ended December 31, 2005 will
report information related to the business and operating results of Northern Way
Resources, Inc., as opposed to the business and operating results of the newly
combined company. As a result of the merger and the change in the Registrant's
fiscal year end to December 31, the Registrant's next periodic report will be a
report on Form 10-KSB for the period ended December 31, 2005 and will be filed
by March 31, 2006. The Form 10-KSB will contain information related to the
Registrant's new business and the corresponding operating results for the year
ended December 31, 2005.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Reuben Seltzer (212) 798-8100
- --------------------------------------------------------------------------------
(Name) (Area Code) (Telephone number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Neuro-Hitech Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date February 15, 2005 /s/ Reuben Seltzer
----------------- ----------------------------------------------
Name: Reuben Seltzer
Title: President and Chief Executive Officer
INSTRUCTION. The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of
the representative's authority to sign on behalf of the registrant shall be
filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal criminal
violations. (See 18 U.S.C. 1001).
